VINC

2.44% -0.0003

Dopo l'orario di chiusura: .01 -0.002 -16.67%

Vincerx Pharma Inc (VINC)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Vincerx Pharma Inc Stock (VINC) Company Profile

Vincerx Pharma Inc

Healthcare (1133)

Biotechnology (634)

Prossima data di guadagno

Ultimi documenti SEC

VINC's Discussions on Twitter

Confronta VINC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VINC Vincerx Pharma Inc	0.012	0	0	-48.85M	-46.25M	-2.31
VRTX Vertex Pharmaceuticals Inc	455.48	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	718.36	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.12	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	901.17	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.00	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-01-14	Iniziato	H.C. Wainwright	Buy
2021-12-23	Iniziato	Cantor Fitzgerald	Overweight
2021-11-01	Iniziato	SVB Leerink	Outperform
2021-09-13	Iniziato	Laidlaw	Buy
2021-08-25	Iniziato	B. Riley Securities	Buy

Vincerx Pharma Inc Borsa (VINC) Ultime notizie

Vincerx Pharma Inc Azioni (VINC) Dati Finanziari

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Stock (VINC) Company Profile

Confronta VINC con altri titoli

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Vincerx Pharma Inc Borsa (VINC) Ultime notizie

Vincerx Pharma, Inc. (VINC) Stock forecasts - Yahoo

Analyzing Neoleukin Therapeutics (NASDAQ:NLTX) & Vincerx Pharma (NASDAQ:VINC) - Defense World

Vincerx Pharma, Inc. (VINC) stock price, news, quote and history - Yahoo

Vincerx Pharma, Inc.Common Stock (NQ: VINC - FinancialContent

Vincerx Pharma ends sales agreement, approves reverse stock split - MSN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders - ACCESS Newswire

Vincerx Pharma (NASDAQ:VINC) vs. NovaBay Pharmaceuticals (NYSE:NBY) Financial Survey - Defense World

Vincerx Pharma, Inc. Announces Additional Adjournment of - GlobeNewswire

Vincerx Warns Stockholders: Delayed Dissolution Vote Threatens $0.07 Per Share DistributionAction Required - Stock Titan

Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders - The Manila Times

Vincerx announces potential distribution of $0.04-$0.08 per share By Investing.com - Investing.com South Africa

Vincerx announces potential distribution of $0.04-$0.08 per share - Investing.com

Vincerx Pharma, Inc. Urges Stockholders to Vote FOR - GlobeNewswire

Vincerx Pharma Stockholders Face Critical July 16 Vote: $0.08 Per Share at Stake in Dissolution Plan - Stock Titan

Vincerx Pharma enters at-the-market equity offering deal - MSN

Vincerx Pharma, Inc. Announces Adjournment of Special MeetingWill Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal - GlobeNewswire

Vincerx Pharma Stockholders Risk Losing All Distribution Value if Dissolution Vote Fails by July 16 - Stock Titan

At a crossroads, biotechs are passing on reverse mergers in 2025 - Endpoints News

TC BioPharm’s $100M Shelf Offering: A Beacon of Resilience in a Collapsing Biotech Landscape - AInvest

VINC Stock Price and Chart — OTC:VINC - TradingView

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com UK

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com UK

Vincerx prepares to wind down as final merger attempt collapses - Fierce Biotech

Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals

Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com

Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World

Vincerx Pharma Inc. (VINC) reports earnings - qz.com

Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire

Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On - insights.citeline.com

Vincerx Pharma Plunges After Scrapping Reverse Merger With Oqory And Vivaso - Nasdaq

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - GlobeNewswire

VINC stock touches 52-week low at $1.3 amid market challenges - Investing.com

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258 - Yahoo Finance

Vincerx Pharma, Inc. Announces 1-for-20 Reverse Stock Split Effective January 27, 2025 - Nasdaq

Palo Alto's Vincerx Pharma plans reverse stock split amid merger plans - The Business Journals

Vincerx Pharma, Inc. Announces Reverse Stock Split - GlobeNewswire

Vincerx Pharma ends sales agreement, approves reverse stock split By Investing.com - Investing.com UK

Investor law firms question biotech merger's 'fairness' - The Business Journals

Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc.VINC | FinancialContent - FinancialContent

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

PRN_FinancialWrapper - FinancialContent

Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish - Stocktwits

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - Yahoo Finance

Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Stocktwits

Vincerx Pharma Reports Promising Cancer Drug Results, Explores Strategic Options Amid Cost Cuts - Stock Titan

Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - qz.com

What Makes Vincerx Pharma (VINC) a New Buy Stock - Yahoo Finance

VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges - Investing.com

Vincerx Pharma Inc Azioni (VINC) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a VINC